Invention Grant
- Patent Title: d-methadone for the treatment of psychiatric symptoms
-
Application No.: US15204052Application Date: 2016-07-07
-
Publication No.: US09855226B2Publication Date: 2018-01-02
- Inventor: Paolo L. Manfredi , Charles E. Inturrisi
- Applicant: Relmada Therapeutics, Inc.
- Applicant Address: US NY New York
- Assignee: Relmada Therapeutics, Inc.
- Current Assignee: Relmada Therapeutics, Inc.
- Current Assignee Address: US NY New York
- Agency: Wood Herron & Evans LLP
- Main IPC: A61K31/137
- IPC: A61K31/137 ; A61K45/06 ; A61K9/19 ; A61K9/00

Abstract:
The present invention relates to a method of treating psychiatric symptoms in a subject having a NMDA receptor and a NE receptor which includes administering d-methadone, d-methadol, d-alpha-acetylmethadol, l-alpha-acetylmethadol, d-alpha-normethadol, l-alpha-normethadol, pharmaceutically acceptable salts thereof, or mixtures thereof, to the subject under conditions effective for the substance to bind to the NMDA receptor and NE receptor of the subject.
Public/Granted literature
- US20160310450A1 d-Methadone for the Treatment of Psychiatric Symptoms Public/Granted day:2016-10-27
Information query